1. Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's disease. Issue 10 (23rd September 2015) Authors: Feagan, B. G.; Sandborn, W. J.; D'Haens, G.; Lee, S. D.; Allez, M.; Fedorak, R. N.; Seidler, U.; Vermeire, S.; Lawrance, I. C.; Maroney, A. C.; Jurgensen, C. H.; Heath, A.; Chang, D. J. Journal: Alimentary pharmacology & therapeutics Issue: Volume 42:Issue 10(2015) Page Start: 1170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗